Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Trial of d4T, ddI, Nelfinavir and Hydroxyurea in Early Asymptomatic HIV
NCT00002176Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- May 1997
- Primary completion
- Mar 2000
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxyurea in human immunodeficiency virus infection (HIV), sponsored by Bristol Myers Squibb. Started May 1997; status: completed.
02
Drugs
hydroxyurea
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00002176.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002176.